Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2026-01-02 @ 4:38 PM
Study NCT ID:
NCT01920958
Status:
COMPLETED
Last Update Posted:
2016-12-19
First Post:
2013-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Use of Tachosil® for Lymph Sealing During Surgery
Sponsor:
Takeda
Organization:
Study Overview
Official Title:
Use of Tachosil® for Lymph Sealing During Surgery. A Non-Interventional Study
Status:
COMPLETED
Status Verified Date:
2016-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SEAL
Brief Summary:
The purpose of this study is to describe effectiveness and reliability of TachoSil® in lymph sealing after lymphadenectomy.
Detailed Description:
The aim of this non-interventional study (NIS) was to collect further knowledge on the routine use of TachoSil ® in lymph node surgery where its sealing property helps to reduce the rate of postoperative complications, especially of seroma formation. Some data are already available from gynecology, urology and thoracic surgery.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| U1111-1142-0279 | REGISTRY | WHO | View |